Amos Lal

3.6k total citations
137 papers, 1.2k citations indexed

About

Amos Lal is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Amos Lal has authored 137 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 37 papers in Pulmonary and Respiratory Medicine and 29 papers in Surgery. Recurrent topics in Amos Lal's work include COVID-19 Clinical Research Studies (28 papers), Long-Term Effects of COVID-19 (18 papers) and Respiratory Support and Mechanisms (13 papers). Amos Lal is often cited by papers focused on COVID-19 Clinical Research Studies (28 papers), Long-Term Effects of COVID-19 (18 papers) and Respiratory Support and Mechanisms (13 papers). Amos Lal collaborates with scholars based in United States, India and Italy. Amos Lal's co-authors include Ajay Kumar Mishra, Kamal Kant Sahu, Jamal Akhtar, Mohammad Saud Khan, Anu Anna George, Vijairam Selvaraj, Kevin John, Ognjen Gajic, Arkadiy Finn and Kwame Dapaah-Afriyie and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Amos Lal

124 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amos Lal United States 18 478 235 218 175 164 137 1.2k
Xiangdong Guan China 19 455 1.0× 246 1.0× 258 1.2× 233 1.3× 452 2.8× 84 1.6k
Abu Baker Sheikh United States 19 719 1.5× 159 0.7× 158 0.7× 211 1.2× 191 1.2× 145 1.6k
Qiang Fang China 17 434 0.9× 119 0.5× 201 0.9× 237 1.4× 288 1.8× 76 1.5k
Dhan Bahadur Shrestha Nepal 18 263 0.6× 153 0.7× 162 0.7× 131 0.7× 137 0.8× 168 1.1k
Eun Young Choi South Korea 18 363 0.8× 173 0.7× 138 0.6× 150 0.9× 145 0.9× 51 1.0k
Yinghui Xu United States 18 429 0.9× 143 0.6× 309 1.4× 146 0.8× 168 1.0× 91 1.8k
Leonidas Palaiodimos United States 16 706 1.5× 345 1.5× 138 0.6× 170 1.0× 296 1.8× 82 1.4k
Su Hwan Lee South Korea 17 353 0.7× 119 0.5× 349 1.6× 199 1.1× 303 1.8× 79 1.3k
Asim Kichloo United States 16 209 0.4× 209 0.9× 160 0.7× 309 1.8× 229 1.4× 138 1.6k
Patricia Harrington Ireland 21 789 1.7× 89 0.4× 160 0.7× 144 0.8× 340 2.1× 79 1.7k

Countries citing papers authored by Amos Lal

Since Specialization
Citations

This map shows the geographic impact of Amos Lal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amos Lal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amos Lal more than expected).

Fields of papers citing papers by Amos Lal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amos Lal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amos Lal. The network helps show where Amos Lal may publish in the future.

Co-authorship network of co-authors of Amos Lal

This figure shows the co-authorship network connecting the top 25 collaborators of Amos Lal. A scholar is included among the top collaborators of Amos Lal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amos Lal. Amos Lal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lal, Amos, et al.. (2025). Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease- A Growing Threat Beyond the Liver. Current Atherosclerosis Reports. 27(1). 108–108.
2.
Kılıçkaya, Oğuz, et al.. (2024). Advances and utility of digital twins in critical care and acute care medicine: a narrative review. SHILAP Revista de lepidopterología. 42. 9–9. 2 indexed citations
3.
4.
Tekin, Aysun, Lucrezia Rovati, Amos Lal, et al.. (2023). The Diagnostic Accuracy of Metagenomic Next-Generation Sequencing in DiagnosingPneumocystisPneumonia: A Systemic Review and Meta-analysis. Open Forum Infectious Diseases. 10(9). ofad442–ofad442. 7 indexed citations
5.
Lal, Amos, et al.. (2023). Septic shock definitions and associated outcomes in blood culture positive critically ill patients. Annals of Translational Medicine. 11(5). 192–192. 5 indexed citations
6.
Lal, Amos, et al.. (2023). Acute on chronic liver failure: prognostic models and artificial intelligence applications. Hepatology Communications. 7(4). 2 indexed citations
7.
Odeyemi, Yewande, Amos Lal, Erin F. Barreto, et al.. (2023). Early machine learning prediction of hospitalized patients at low risk of respiratory deterioration or mortality in community-acquired pneumonia: Derivation and validation of a multivariable model. SHILAP Revista de lepidopterología. 24(2). 337–345. 4 indexed citations
8.
Lal, Amos, et al.. (2023). Pulmonary Cryptococcosis and Pulmonary Fibrosis: A Complication of COVID-19 Pneumonia. Cureus. 15(3). e35660–e35660. 2 indexed citations
9.
Chlan, Linda L., et al.. (2023). The impact of the COVID-19 pandemic on ICU clinical trials: a description of one research team’s experience. Trials. 24(1). 321–321. 2 indexed citations
10.
John, Kevin, et al.. (2022). A Review of Nuclear Imaging in Takotsubo Cardiomyopathy. Life. 12(10). 1476–1476. 6 indexed citations
11.
Selvaraj, Vijairam, Arkadiy Finn, Amos Lal, et al.. (2022). Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials. EClinicalMedicine. 49. 101489–101489. 57 indexed citations
12.
Garcia, Michael A., Shelsey W. Johnson, R. Christopher Sheldrick, et al.. (2022). Variation in Use of High-Flow Nasal Cannula and Noninvasive Ventilation Among Patients With COVID-19. Respiratory Care. 67(8). 929–938. 4 indexed citations
13.
John, Kevin, et al.. (2021). A review of the presentation and outcome of sarcoidosis in COVID-19. Journal of Clinical and Translational Research. 2 indexed citations
14.
Koritala, Thoyaja, Vishwanath Pattan, Raghavendra Tirupathi, et al.. (2021). Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review. Infezioni in Medicina. 29(4). 495–503. 15 indexed citations
15.
John, Kevin, Anu Anna George, Kamal Kant, et al.. (2021). A review of the oresentation and outcome of left ventricular thrombus in COVID-19 infection. Journal of Clinical and Translational Research. 1 indexed citations
16.
Chalmers, Sarah, Yewande Odeyemi, Amos Lal, et al.. (2021). F IO 2 Trajectory as a Pragmatic Intermediate Marker in Acute Hypoxic Respiratory Failure. Respiratory Care. 66(10). 1521–1530. 2 indexed citations
17.
Sahu, Kamal Kant, et al.. (2020). Testicular Lymphoma: A Rare Cause of a Testicular Mass. Journal of College of Physicians And Surgeons Pakistan. 30(5). 556–556. 2 indexed citations
18.
Sahu, Kamal Kant, et al.. (2020). Mesenteric Hematoma: Challenges in Diagnosis and Management. Journal of College of Physicians And Surgeons Pakistan. 30(6). 667–668.
19.
Seyran, Murat, Damiano Pizzol, Parise Adadi, et al.. (2020). Unique features concerning the proximal origin of SARS-CoV-2. Digital Commons - University of South Florida (University of South Florida). 2 indexed citations
20.
Lal, Amos, et al.. (2019). Detection of coexisting toxigenic Clostridium difficile and nontyphoidal Salmonella in a healthcare worker with diarrhea: A therapeutic dilemma. SHILAP Revista de lepidopterología. 8(8). 2724–2724. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangdong Guan Breakdown of academic impact, for papers by Abu Baker Sheikh Breakdown of academic impact, for papers by Qiang Fang Breakdown of academic impact, for papers by Dhan Bahadur Shrestha Breakdown of academic impact, for papers by Eun Young Choi Breakdown of academic impact, for papers by Yinghui Xu Breakdown of academic impact, for papers by Leonidas Palaiodimos Breakdown of academic impact, for papers by Su Hwan Lee Breakdown of academic impact, for papers by Asim Kichloo Breakdown of academic impact, for papers by Patricia Harrington
Rankless by CCL
2026